We made predictions about the specialty drug market. Here’s how we did.

Early this year, we wrote the blog post, What’s next for specialty? Seven predictions for 2016. It turned out to be...

Read More

Why specialty drugs may be worth the cost

Specialty drug prices have tripled since 2003, when they represented just 11% of payer drug spending. In 2014, that...

Read More

[Infographic] What factors impact MS treatment adherence?

The more patients with multiple sclerosis (MS) talk with their health care providers, the better. A close...

Read More

How to better manage specialty drug orders

It’s no secret managing specialty drugs is inefficient and time consuming for providers. What you may find...

Read More
Page 4 of 9
« 1 ...
2 3 4 5 6
... 9 »